Related Experiment Videos

Letter: Hepatitis-B core antigen and antibody in primary liver cancer

S J Hadziyannis, G G Karvountzis, E Manesis

Lancet (London, England)

|August 30, 1975

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Keratin 7 expression in hepatic cholestatic diseases.

Virchows Archiv : an international journal of pathology·2021

Real-life cost of managing chronic HCV infection in Greece prior to Direct-Acting Antivirals (DAAs): an undeniable truth of spending more for less.

Hippokratia·2019

Association of antiviral therapy with reduced disease progression in chronic Hepatitis B patients: Results from a nation-wide cohort study.

Hippokratia·2017

Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

Alimentary pharmacology & therapeutics·2015

Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.

Hippokratia·2014

Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.

Journal of viral hepatitis·2014

See all related articles